{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:34:39Z","timestamp":1788345279906,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.euf.2021.01.005","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T20:12:58Z","timestamp":1611951178000},"page":"320-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Benefits and Harms of Botulinum Toxin-A in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel"],"prefix":"10.1016","volume":"8","author":[{"given":"Brian A.","family":"Parsons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchia","family":"Goonewardene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Dabestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Pacheco-Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Zumstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Borovicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Dinis-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bary","family":"Berghmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohier","family":"Elneil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert E.J.","family":"Messelink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C.","family":"de C Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Baranowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Engeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2021.01.005_bib0005","series-title":"EAU guidelines on chronic pelvic pain","author":"Engeler","year":"2018"},{"key":"10.1016\/j.euf.2021.01.005_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1749-6632.2001.tb05822.x","article-title":"Central neuroplasticity and pathological pain","volume":"933","author":"Melzack","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.euf.2021.01.005_bib0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.eururo.2008.03.073","article-title":"Chronic pelvic pain and lower urinary tract symptoms in both sexes: analysis of 2749 participants of an urban health screening project","volume":"55","author":"Marszalek","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.01.005_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3344\/kjp.2011.24.1.1","article-title":"Application of botulinum toxin in pain management","volume":"24","author":"Sim","year":"2011","journal-title":"Korean J Pain"},{"key":"10.1016\/j.euf.2021.01.005_bib0025","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/ACO.0b013e32833c3405","article-title":"The role of botulinum toxin in management of pain: an evidence-based review","volume":"23","author":"Qerama","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.euf.2021.01.005_bib0030","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.21427","article-title":"Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain","volume":"64","author":"Ranoux","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.euf.2021.01.005_bib0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tox.2013.02.006","article-title":"Botulinum toxins: mechanisms of action, antinociception and clinical applications","volume":"306","author":"Wheeler","year":"2013","journal-title":"Toxicology"},{"issue":"6 Suppl","key":"10.1016\/j.euf.2021.01.005_bib0040","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/00002508-200211001-00002","article-title":"Therapeutic use of botulinum toxins: background and history","volume":"18","author":"Setler","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.euf.2021.01.005_bib0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/2046-4053-2-40","article-title":"A comparative assessment of three formulations of botulinum toxin A for facial rhytides: a systematic review and meta-analyses","volume":"2","author":"Bonaparte","year":"2013","journal-title":"Syst Rev"},{"key":"10.1016\/j.euf.2021.01.005_bib0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/toxins8030065","article-title":"Conversion ratio between Botox\u00ae, Dysport\u00ae, and Xeomin\u00ae in clinical practice","volume":"8","author":"Scaglione","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.euf.2021.01.005_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.euf.2021.01.005_bib0060","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2017.08.016","article-title":"Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology","volume":"73","author":"Knoll","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.01.005_bib0065","series-title":"AHRQ methods for effective health care. Assessing the risk of bias of individual studies in systematic reviews of health care interventions. In: Methods guide for effectiveness and comparative effectiveness reviews","author":"Viswanathan","year":"2008"},{"key":"10.1016\/j.euf.2021.01.005_bib0070","first-page":"7","article-title":"A randomised controlled trial of bacillus Calmette-Guerin and botulinum toxin-A for the treatment of refractory interstitial cystitis","volume":"2","author":"El-Bahnasy","year":"2009","journal-title":"Uro Today Int J"},{"key":"10.1016\/j.euf.2021.01.005_bib0075","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1464-410X.2009.08495.x","article-title":"Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis\/painful bladder syndrome","volume":"104","author":"Kuo","year":"2009","journal-title":"BJU Int"},{"issue":"4 Suppl 1","key":"10.1016\/j.euf.2021.01.005_bib0080","first-page":"e335","article-title":"Randomized controlled trial for efficacy of botulinum toxin type a in treatment of patients suffering bladder pain syndrome\/interstitial cystitis with Hunners\u2019 lesions: preliminary results","volume":"187","author":"Kasyan","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.01.005_bib0085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00192-013-2267-8","article-title":"A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis\/bladder pain syndrome","volume":"25","author":"Manning","year":"2014","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.euf.2021.01.005_bib0090","first-page":"10125","article-title":"Injection location does not impact botulinum toxin A efficacy in interstitial cystitis\/bladder pain syndrome patients","volume":"27","author":"Evans","year":"2020","journal-title":"Can J Urol"},{"key":"10.1016\/j.euf.2021.01.005_bib0095","first-page":"109","article-title":"Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis","volume":"16","author":"Lee","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.euf.2021.01.005_bib0100","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00192-015-2631-y","article-title":"Intravesical injection of botulinum toxin A for treatment of interstitial cystitis\/bladder pain syndrome: 10 years of experience at a single center in China","volume":"26","author":"Gao","year":"2015","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.euf.2021.01.005_bib0105","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/01.AOG.0000237100.29870.cc","article-title":"Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial","volume":"108","author":"Abbott","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.euf.2021.01.005_bib0110","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/j.1743-6109.2009.01378.x","article-title":"Botulinum toxin type A-a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study","volume":"6","author":"Petersen","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2021.01.005_bib0115","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00404-019-05043-w","article-title":"Subcutaneous botulinum toxin type A injections for provoked vestibulodynia: a randomized placebo-controlled trial and exploratory subanalysis","volume":"299","author":"Diomande","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.euf.2021.01.005_bib0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.toxicon.2012.11.018","article-title":"Improvement in pelvic pain with botulinum toxin type A\u2014single vs. repeat injections","volume":"63","author":"Nesbitt-Hawes","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.euf.2021.01.005_bib0125","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/bju.12951","article-title":"Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis\/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study","volume":"116","author":"Falahatkar","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2021.01.005_bib0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.aju.2015.01.001","article-title":"Intraprostatic injection of botulinum toxin-A in patients with refractory chronic pelvic pain syndrome: the transurethral vs. transrectal approach","volume":"13","author":"El-Enen","year":"2015","journal-title":"Arab J Urol"},{"key":"10.1016\/j.euf.2021.01.005_bib0135","first-page":"9273","article-title":"Treatment of refractory category III nonbacterial chronic prostatitis\/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study","volume":"25","author":"Abdel-Meguid","year":"2018","journal-title":"Can J Urol"},{"key":"10.1016\/j.euf.2021.01.005_bib0140","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5144\/0256-4947.2005.140","article-title":"Botulinum toxin injection versus internal anal sphincterotomy for the treatment of chronic anal fissure","volume":"25","author":"Massoud","year":"2005","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.euf.2021.01.005_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.06.044","article-title":"A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain","volume":"221","author":"Dessie","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.euf.2021.01.005_bib0150","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3389\/fneur.2020.00716","article-title":"Botulinum neurotoxin for the treatment of neuropathic pain","volume":"11","author":"Egeo","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.euf.2021.01.005_bib0155","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/01.ju.0000152337.82806.e8","article-title":"A randomized controlled trial of intravesical bacillus Calmette-Guerin for treatment refractory interstitial cystitis","volume":"173","author":"Mayer","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.01.005_bib0160","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/S0022-5347(01)64682-2","article-title":"The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial","volume":"157","author":"Peters","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.01.005_bib0165","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jama.285.4.437","article-title":"Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas","volume":"285","author":"Ioannidis","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.euf.2021.01.005_bib0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1745-6215-15-247","article-title":"Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a\u2019 core outcome set\u2019","volume":"15","author":"Prinsen","year":"2014","journal-title":"Trials"},{"issue":"Suppl 3","key":"10.1016\/j.euf.2021.01.005_bib0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","article-title":"The COMET handbook: version 1.0","volume":"18","author":"Williamson","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.euf.2021.01.005_bib0180","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.ED000041","article-title":"The COMET (Core Outcome Measures in Effectiveness Trials) initiative: its role in improving Cochrane reviews","volume":"5","author":"Williamson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euf.2021.01.005_bib0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pain.2003.08.001","article-title":"Core outcome domains for chronic pain clinical trials: IMMPACT recommendations","volume":"106","author":"Turk","year":"2003","journal-title":"Pain"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456921000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456921000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:52:13Z","timestamp":1762498333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456921000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2405456921000067"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2021.01.005","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Benefits and Harms of Botulinum Toxin-A in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2021.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}